miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer
Shiying Yang,1 Zhen Li,2 Rui Luo3 1Department of Gynecology and Obstetrics, Rizhao People’s Hospital, Rizhao City 276800, Shandong Province, People’s Republic of China; 2Reproductive Medicine Center, Qingdao Women and Children Hospital, Qingdao City 266011, Shandong Province, Peo...
Main Authors: | Yang S, Li Z, Luo R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/mir-34c-targets-met-to-improve-the-anti-tumor-effect-of-cisplatin-on-o-peer-reviewed-article-OTT |
Similar Items
-
miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
by: Lei Dou, et al.
Published: (2021-03-01) -
Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway
by: Qiaoyun Chen, et al.
Published: (2015-06-01) -
LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer
by: Jiang X, et al.
Published: (2021-05-01) -
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
by: Pierre-Antoine Bissey, et al.
Published: (2020-06-01) -
HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
by: Yu-Jie Dong, et al.
Published: (2021-07-01)